Annette von Drygalski
UC San Diego Health System(US)University of California San Diego(US)
Publications by Year
Research Areas
Hemophilia Treatment and Research, Blood Coagulation and Thrombosis Mechanisms, Myeloproliferative Neoplasms: Diagnosis and Treatment, Platelet Disorders and Treatments, Venous Thromboembolism Diagnosis and Management
Most-Cited Works
- → Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B(2023)314 cited
- → Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis(2013)232 cited
- → Vancomycin-Induced Immune Thrombocytopenia(2007)220 cited
- → BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression(2020)183 cited
- → Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A(2023)178 cited
- → Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A(2023)161 cited
- → Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B(2019)